☆ 4.3 Editorial Material

Long-term treatment with anti-CD20 monoclonal antibodies is untenable because of risk - No

MULTIPLE SCLEROSIS JOURNAL (2022)

主要评分表示论文的整体质量水平。次要评分独立反映论文的优点或缺点。

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discuss science. Find collaborators. Network.

Join a conversation